Catasys Inc (CATS) 1.1700 $CATS Catasys Reports Second

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Catasys Inc (CATS) 1.1700 $CATS

Catasys Reports Second Quarter 2016 Financial Results
PR Newswire - Tue Aug 16, 7:00AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling and integrated treatment programs for substance dependence, depression and anxiety on behalf of health plans, today reported financial results for the second quarter ended June 30, 2016.

Healthcare Stocks' Q2 Earnings in Queue: CATS & FDNH
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 8:05AM CDT
Here we take a look at two Healthcare stocks lined up to report their quarterly numbers.

Total Phase Flash Center Software Now Includes Support for More Memory Chips Than Every Before
PRWeb - Wed Aug 10, 8:26AM CDT
Total Phase, a leading provider of embedded systems development tools, is pleased to announce the release of updates to the Flash Center™ Software, a free I2C and SPI EEPROM and Flash memory programming GUI.
ATML: 8.14 (+0.02), ISSI: 22.91 (+0.03)

Catasys Expands Rollout of OnTrak-A Solution in Oklahoma with Leading National Health Insurance Provider
PR Newswire - Tue Jun 07, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-A solution in Oklahoma with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys to Participate in LD Micro Invitational on June 7, 2016
PR Newswire - Wed Jun 01, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that Terren Peizer, Chairman of the Board and CEO, will present at the LD Micro Invitational to be held at the Luxe Sunset Bel Air in Los Angeles on Tuesday, June 7, 2016 at 12:00 pm PT.

Catasys Expands Rollout of OnTrak-H Solution in Texas with Leading National Health Insurance Provider
PR Newswire - Wed May 18, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-H solution in Texas with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys to Participate in Joseph Gunnar's Pioneers 2016 Conference on May 5, 2016
PR Newswire - Thu Apr 28, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that Terren Peizer, Chairman of the Board and CEO, will present at Joseph Gunnar's Pioneers 2016 Conference to be held at the New York Palace Hotel in New York City on Thursday, May 5, 2016 at 2:00 pm ET.

Catasys Expands Rollout of OnTrak-H Solution in Louisiana with Leading National Health Insurance Provider
PR Newswire - Mon Apr 18, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-H solution in Louisiana with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys Reports Full Year 2015 Financial Results
PR Newswire - Thu Mar 31, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling based behavioral health management services for health plans, today reported financial results for the full year ended December 31, 2015.

Catasys Expands Rollout of OnTrak-H Solution in Illinois with Leading National Health Insurance Provider
PR Newswire - Thu Mar 24, 7:30AM CDT
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-H solution in Illinois with one of the nation's leading health plans. The plan's eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys Expands Rollout of OnTrak-H Solution in Pennsylvania with Leading National Health Insurance Provider
PR Newswire - Thu Mar 10, 7:30AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-H solution in Pennsylvania with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys Expands Rollout of OnTrak-A Solution into Illinois with Leading National Health Insurance Provider
PR Newswire - Tue Mar 08, 9:06AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-A solution in Illinois with one of the nation's leading health plans. The plan's eligible commercial members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

/C O R R E C T I O N -- Catasys, Inc./
PR Newswire - Wed Jan 20, 9:38AM CST
In the news release, Catasys Expands Rollout of OnTrak-H Solution into Wisconsin with Leading National Health Insurance Provider, issued Jan. 20, 2016 by Catasys, Inc. over PR Newswire, we are advised by the company that there has been an update to the text. The complete, corrected release follows:

Catasys Expands Rollout of OnTrak-H Solution into Wisconsin with Leading National Health Insurance Provider
PR Newswire - Wed Jan 20, 7:30AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-H solution in Wisconsin with one of the nation's leading health plans. The plan's eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys Expands Rollout of OnTrak-A Solution into Pennsylvania with Leading National Health Insurance Provider
PR Newswire - Mon Dec 07, 7:30AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-A solution in Pennsylvania with one of the nation's leading health plans. The plan's eligible commercial members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys Expands Rollout of OnTrak-A Solution into Missouri with Leading National Health Insurance Provider
PR Newswire - Wed Dec 02, 7:30AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak(TM)-A solution in Missouri with one of the nation's leading health plans. The plan's eligible commercial and Medicare Advantage members will be covered under OnTrak-A, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching.

Catasys Signs National Agreement with Humana
PR Newswire - Tue Nov 24, 7:31AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary big-data based analytics and predictive modeling driven health management services for health plans, announced today that it has signed a national agreement with Humana Behavioral Health to combine its substance abuse care management with Humana clinical programs to address the needs of members experiencing substance abuse challenges. Humana Behavioral Health is a subsidiary of Humana Inc.
HUM: 179.63 (unch)

Catasys Reports Third Quarter 2015 Financial Results
PR Newswire - Mon Nov 16, 8:03AM CST
Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics modeling based behavioral health management services for health plans, today reported financial results for the third quarter ended September 30, 2015.

Crystal Research Associates Issues Executive Informational Overview (EIO) on Catasys
PR Newswire - Mon Sep 21, 6:30AM CDT
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Catasys, Inc. (CATS-OTCQB). The full 56-page report is available on Crystal Research Associates' website at www.crystalra.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

b1BANK Partners with Spiral to Enhance Community Banking Impact

Updated Category News Views 97

Enhanced Financial Wellness through Partnership NEW YORK--Today, Spiral, a personalized banking platform, announced a significant partnership with b1BANK, established as a community-focused banking institution. Through this collaboration, the two organizations aim to enhance financial wellness for customers, leveraging b1BANK's dedication to innovative banking solutions...

Continue Reading
AM Best Explores Trends Influencing For-Hire Trucking Industry

Updated Category News Views 168

Insights from AM Best's Latest Webinar on Trucking Trends Viewers can now delve into the highlights from the enlightening webinar hosted by AM Best, titled "For-Hire Trucking: The Risky Road Ahead." This event focused on the intricacies and challenges within the transportation-for-hire trucking sector, providing expert insights into risk management strategies and the...

Continue Reading
BitMart's Creative Campaign to Ignite Offline Crypto Engagement

Updated Category News Views 135

Introducing the Fox Hunt Delivery Campaign BitMart, a leading global cryptocurrency exchange, is excited to announce the launch of the Fox Hunt Delivery Campaign, a unique initiative aimed at boosting cryptocurrency adoption through engaging offline activities. This campaign offers an exciting chance for participants to earn USDT rewards simply by introducing new users to...

Continue Reading
Trinity Capital Inc. Fuels Alt Platform's Growth with $40M Credit

Updated Category News Views 273

Trinity Capital Inc. Supports Alt with Significant Credit Facility Trinity Capital Inc. (NASDAQ: TRIN), a prominent alternative asset manager, is thrilled to announce a groundbreaking agreement with Alt, providing up to $40 million through an asset-based revolving credit facility. This funding aims to bolster Alt's innovative marketplace tailored for trading card...

Continue Reading
Everest Medicines Achieves Record Revenue and Growth in 2024

Updated Category News Views 506

Everest Medicines Achieves Remarkable Financial Success Everest Medicines, a groundbreaking biopharmaceutical company focused on innovative healthcare solutions, has reported remarkable financial results for the year ending December 31, 2024. With a robust revenue growth of 461%, the company stands out in the pharmaceutical industry, showcasing its resilience and dynamic...

Continue Reading